Glyburide (RP-1127) for Traumatic Brain Injury (TBI)

Clinical trial NCT01454154 · COMPLETED

Trial details

NCT number: NCT01454154
Sponsor: Remedy Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Traumatic Brain Injury

Start date: 2011-12-17
Primary completion: 2015-02-20
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.